Proliferative vitreoretinopathy: Immunoreactive endothelin-1
Tóm tắt
Endothelin-1 is a potent vasoconstrictive and neural peptide functionally active in the eye. We demonstrated that the concentration of immunoreactive endothelin-1 in subretinal fluid was higher in patients with proliferative vitreoretinopathy (PVR) vs. uncomplicated retinal detachment. No differences in plasma concentrations of immunoreactive endothelin-1 were found. Intraocular synthesis of endothelin-1 may play a role in the pathogenesis of PVR.
Tài liệu tham khảo
Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by endothelial cells. Nature (London). 1988; 332:411–5.
Battistini B, Chailler P, D'Orleans-Juste P, Brière N, Sirois P. Growth regulatory properties of endothelins. Peptides. 1993;14:385–9.
Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of cDNA encoding and endothelin receptor. Nature (London) 1990;348:730–2.
Sakurai T, Yanagisawa M, Takuwa Y, et al. Cloning of cDNA encoding a non isopeptide selective subtype of endothelin receptor. Nature (London) 1990;348:732–5.
Sakurai T, Yanagisawa M, Masaki T. Molecular characterisation of endothelin receptor. Trends Pharmacol Sci. 1992;13:103–8
Warner TD, Mitchell JA, De Nucci G, Vane JR. Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and rabbit. J Cardiovas Pharmacol. 1989;13:S85-S88.
Inoue A, Yanagisawa M, Kimura S, et al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA. 1989;86:2863–7.
MacKumber MW, Jampel HD, Snyder SH. Ocular effect of endothelin. Arch Ophthalmol. 1991;109:705–9.
Chakravarthy U, Douglas AJ, Bailie JR, McKibben B, Archer DB. Immunoreactive endothelin distribution in ocular tissues. Invest Ophthalmol Vis Sci. 1994;35:2448–54.
Ripodas A, de Juan JA, Roldán-Pallarés M, et al. Localisation of Endothelin-1 mRNA expression and immunoreactivity in the retina and optic nerve from human and procine eye. Evidence for endothelin-1 expression in astrocytes. Brain Res. 2001;912:137–143.
Rachal WF, Burton TC. Changing concepts of failures after retinal detachment surgery. Arch Opthalmol 1979;97:480–3.
The Retinal Society Terminology Commitee. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology. 1983;90:121–5.
Ryan SJ. The pathophysiology of proliferative vitreoretinopathy and its management. Am J Ophthalmol. 1985;100:188–93.
Smith-Thomas L, Haycock JW, Metcalfe R. Involvement of calcium in retinal pigment epithelial cell proliferation and pigmentation. Curr Eye Res. 1998;8:813–822.
Lincoff H, Baras I, McLean JM. Modifications to the Custodis procedure for retinal detachment. Arch Ophthalmol. 1965;73:160–3
Machemer R, Aaberg TM, Freeman HM, Irvine AR, Lean JS, Michels RM. An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol. 1991;112:159–165.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265–275.
Huerva V, Sinues B, Canto LM, Lanuza J, Palomar A Apoprotein B in subretinal fluid. Int Ophthalmol. 1996-97;20:181–5.
De Juan JA, Moya FJ, García de la Coba M, Fernández-Cruz A, Fernández-Durango R. Identification and characterization of endothelin receptor subtype B (ETB) in rat retina. J Neurochem. 1993;61:1113–9.
Limb GA, Little BC, Meager A. Cytokines in proliferative vitreoretinopathy. Eye. 1991;5:686–693.
Kauffmann DJ, Van Meurs JC, Mertens DA, Peperkamp E, Master C, Gerritsen ME. Cytokines in vitreous humor: Interleukin-6 is elevated in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 1994;35:900–6.
Kosnosky W, Li TH, Pakalnis VA, Fox A, Hunt RC. Interleukin-1-beta changes the expression of metalloproteinases in the vitreous humor and induces membrane formation in eyes containing preexisting retinal holes. Invest Ophthalmol Vis Sci. 1994;35:4260–7.
Schweigerer L, Malerstein B, Neufeld G, Gospodarowicz D. Basic fibroblast growth factor is synthesized in cultured retinal pigment epithelial cells. Biochem Biophys Res Commun. 1987;143:934–40.
Baudouin C, Fredj-Reygrobellet D, Brignole F, Negre F, Lapalus P. Growth factors in vitreous and subretinal fluid cells from patients with proliferative vitreoretinopathy. Ophthalmic Res. 1993;25:52–9.
Grisanti S, Wiedermann P, Heimann K. Die proliferative vitreoretinopathie. Zur bedutung des proteintransfers durch die blutretia-schranke. Ophtalmologie. 1993;90:468–71.
Grisanti S, Guidry C, Heimann K. Contraction of extracellular matrix by transdifferentiated retinal pigment epithelial cells, inducers and inhibitors. Opthalmologe. 1996;93:709–13.
Matsura A, Kawashima S, Yamochi W, et al. Vascular endothelial growth factor increases endothelin-converting enzyme expression in vascular endothelial cells. Biochem Biophys Res Commun. 1997; 235:713–6.
Connor TB Jr, Roberts AB, Sporn MB, et al. Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J. Clin Invest. 1989;83:1661–6.